Everest Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 23-06-2024
- Paid Up Capital ₹ 0.12 M
as on 23-06-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 23-06-2024
- Revenue 779.00%
(FY 2022)
- Profit -34.35%
(FY 2022)
- Ebitda -674.90%
(FY 2022)
- Net Worth -5.76%
(FY 2022)
- Total Assets 8.16%
(FY 2022)
About Everest Laboratories
The Corporate was formerly known as Parshvanath Bricks India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹2.50 M.
Maganlal Patel and Jasmin Baldha serve as directors at the Company.
- CIN/LLPIN
U24239GJ2013PTC081709
- Company No.
081709
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Everest Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maganlal Patel  | Additional Director | 01-Mar-2018 | Current |
| Jasmin Baldha | Additional Director | 31-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Everest Laboratories.
Everest Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 779% increase. The company also saw a substantial fall in profitability, with a 34.35% decrease in profit. The company's net worth dipped by a decrease of 5.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Everest Laboratories?
In 2018, Everest Laboratories had a promoter holding of 24.19% and a public holding of 75.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Apr 2021 | ₹2.50 M | Open |
How Many Employees Work at Everest Laboratories?
Unlock and access historical data on people associated with Everest Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everest Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everest Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
